CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- S-8 Other Securities Offered to Employees in Benefit Plans
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CERT Other Certification
- 8-A12B Other Registration of Securities
- FWP Offering Free Writing Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D/A Other Amended Notice of Exempt Offering of Securities
Page 4 of 5 · 83 filings